Amisulpride-induced neuroleptic malignant syndrome [19]

Basit Öğe Kaydı
dc.authorscopusid6602976945
dc.authorscopusid23009083800
dc.contributor.authorAbay E.
dc.contributor.authorKose R.
dc.date.accessioned2024-06-12T10:25:34Z
dc.date.available2024-06-12T10:25:34Z
dc.date.issued2007
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1176/jnp.2007.19.4.488
dc.identifier.endpage489en_US
dc.identifier.issn0895-0172
dc.identifier.issue4en_US
dc.identifier.pmid18070872en_US
dc.identifier.scopus2-s2.0-36348975169en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage488en_US
dc.identifier.urihttps://doi.org/10.1176/jnp.2007.19.4.488
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16400
dc.identifier.volume19en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAmerican Psychiatric Publishing Inc.en_US
dc.relation.ispartofJournal of Neuropsychiatry and Clinical Neurosciencesen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAmisulpride; Antidepressant Agent; Bromocriptine; Lithium; Olanzapine; Aged; Bipolar Disorder; Case Report; Consciousness Disorder; Diaphoresis; Drug Substitution; Drug Withdrawal; Fever; Human; Hypertension; Letter; Male; Metabolic Disorder; Neuroleptic Malignant Syndrome; Priority Journal; Stuporen_US
dc.titleAmisulpride-induced neuroleptic malignant syndrome [19]en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu